421 results on '"Donson, Andrew M."'
Search Results
52. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma
53. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma.
54. RARE-15. Astroblastoma, MN1 altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners BEND2 and CXXC5
55. EPEN-26. Chemokine receptor blockade reverses CCL2 mediated immunosuppression and restores CAR-T cell function in posterior fossa ependymoma
56. Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
57. PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem.
58. Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas
59. Mapping pediatric brain tumors to their origins in the developing cerebellum
60. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation
61. Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA
62. Glycation of Glutamate Cysteine Ligase by 2-Deoxy-d-Ribose and its Potential Impact on Chemoresistance in Glioblastoma
63. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells
64. Myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant, arising in midbrain tectum with multifocal CSF dissemination
65. Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells
66. Pediatric Brainstem Gangliogliomas Show BRAFV600E Mutation in a High Percentage of Cases
67. Preclinical High-Dose Acetaminophen With N-Acetylcysteine Rescue Enhances The Efficacy of Cisplatin Chemotherapy in Atypical Teratoid Rhabdoid Tumors
68. PDGFB:APOBEC3Cfusion in congenital diffuse high-grade glioma of the brainstem
69. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features
70. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma
71. Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas
72. Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor
73. Predicting which children are at risk for ependymoma relapse
74. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas
75. Measurement of Tamoxifen-Induced Apoptosis in Glioblastoma by Cytometric Bead Analysis of Active Caspase-3
76. Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes
77. Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Expression Is an Independent Prognostic Factor in Pediatric Pilocytic and Pilomyxoid Astrocytoma
78. Protein Kinase C ζ Isoform is Critical for Proliferation in Human Glioblastoma Cell Lines
79. Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry
80. Survey of MicroRNA expression in pediatric brain tumors
81. Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma
82. Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology
83. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups
84. In vitro benchmarking of NF-κB inhibitors
85. MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)
86. Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
87. Tumor Vaccination for Malignant Brain Tumors
88. Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors
89. Adenovirus Mediated Gene Therapy in a Glioblastoma Vaccine Model; Specific Antitumor Immunity and Abrogation of Immunosuppression
90. PARP1 expression in pediatric central nervous system tumors1
91. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
92. Myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant, arising in midbrain tectum with multifocal CSF dissemination.
93. Unique Molecular Characteristics of Radiation-Induced Glioblastoma
94. Mgmt Promoter Methylation Correlates With Survival Benefit and Sensitivity To Temozolomide in Pediatric Glioblastoma
95. Gefitinib Is Effective Against Juvenile Pilocytic Astrocytoma in Vitro
96. Paired Overexpression of ErbB3 and Sox10 in Pilocytic Astrocytoma
97. Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells
98. Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
99. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors
100. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.